Drug intelligence / Profile preview

beclomethasone dipropionate + salbutamol

Development stage
Unknown
Lead developer
Midas Care
Modality
Small Molecules
Administration
Inhalation, Intranasal
01

Overview

Beclomethasone dipropionate + salbutamol is a fixed-dose combination inhaler containing two active ingredients used primarily for the treatment and management of asthma and chronic obstructive pulmonary disease (COPD). Salbutamol (also known as albuterol) is a short-acting beta2 adrenergic receptor agonist that acts as a bronchodilator, relaxing airway smooth muscle to rapidly relieve bronchospasm. Beclomethasone dipropionate is an inhaled corticosteroid that reduces inflammation in the airways by inhibiting the release of pro-inflammatory mediators. The combination provides both rapid symptom relief (via salbutamol) and long-term control of airway inflammation (via beclomethasone), making it suitable for maintenance therapy in patients with asthma or COPD who require both components[1][6][2]. This medication is typically administered via metered dose inhaler.

Brand names
VentorideAeroventVent BecAerotide ForteIbires BVent PlusAerotideDurabec Breath
Other names
Salbutamol + Beclometasone
02

Targets

GR (Glucocorticoid receptor)ADRB2 (β2)

Beyond the preview

Go deeper on beclomethasone dipropionate + salbutamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beclomethasone dipropionate + salbutamol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call